168 related articles for article (PubMed ID: 6541892)
1. [Reduction of cisplatin toxicity by fosfomycin in animal models].
Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
[TBL] [Abstract][Full Text] [Related]
2. [Protective effect of fosfomycin on cisplatin-induced ototoxicity in rats].
Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J
Nihon Jibiinkoka Gakkai Kaiho; 1984 Jul; 87(7):833-40. PubMed ID: 6541687
[No Abstract] [Full Text] [Related]
3. [Preventive effect of fosfomycin on the renal toxicity of cisplatin].
Kurebe M; Niizato T; Sanda M; Sasaki H; Hayasaka H
Jpn J Antibiot; 1985 Jan; 38(1):62-8. PubMed ID: 3157808
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cisplatin ototoxicity by fosfomycin in animal model.
Ohtani I; Ohtsuki K; Aikawa T; Anzai T; Ouchi J; Saito T
ORL J Otorhinolaryngol Relat Spec; 1985; 47(5):229-35. PubMed ID: 4047624
[TBL] [Abstract][Full Text] [Related]
5. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
Saleh S; El-Demerdash E
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner.
Ozyurt H; Yildirim Z; Kotuk M; Yilmaz HR; Yağmurca M; Iraz M; Söğüt S; Gergerlioglu S
J Appl Toxicol; 2004; 24(4):269-75. PubMed ID: 15300714
[TBL] [Abstract][Full Text] [Related]
8. HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats.
Takada S; Namiki M; Takahara S; Matsumiya K; Kondoh N; Kitamura M; Uchida K; Koga M; Jiang H; Kokado Y; Kameoka H; Miki T; Matsumoto K; Nakamura T; Okuyama A
Transplant Proc; 1996 Apr; 28(2):1089-90. PubMed ID: 8623236
[No Abstract] [Full Text] [Related]
9. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats.
Tikoo K; Bhatt DK; Gaikwad AB; Sharma V; Kabra DG
FEBS Lett; 2007 May; 581(10):2027-35. PubMed ID: 17470369
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
[TBL] [Abstract][Full Text] [Related]
15. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
16. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum.
Jordan JA; Schwade ND; Truelson JM
Laryngoscope; 1999 Aug; 109(8):1259-62. PubMed ID: 10443830
[TBL] [Abstract][Full Text] [Related]
18. [Morphologic observations on preventional effect of fosfomycin to nephrotoxicity induced by cisplatin].
Ogawa T; Ryoke K; Hamada T
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):84-91. PubMed ID: 3379336
[No Abstract] [Full Text] [Related]
19. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
Engineer MS; Bodey GP; Newman RA; Ho DH
Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307
[TBL] [Abstract][Full Text] [Related]
20. Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport.
Fatima S; Arivarasu NA; Mahmood R
Hum Exp Toxicol; 2007 May; 26(5):419-26. PubMed ID: 17623766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
